Related references
Note: Only part of the references are listed.Caspase-2 mRNA levels are not elevated in mild cognitive impairment, Alzheimer's disease, Huntington's disease, or Lewy Body dementia
Chris C. Hlynialuk et al.
PLOS ONE (2022)
A soluble truncated tau species related to cognitive dysfunction is elevated in the brain of cognitively impaired human individuals
Peng Liu et al.
SCIENTIFIC REPORTS (2020)
Behavioral Abnormalities in Knockout and Humanized Tau Mice
Rafaella Araujo Goncalves et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Tying up loose ends: the N-degron and C-degron pathways of protein degradation
Richard T. Timms et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2020)
Specificity for latent C termini links the E3 ubiquitin ligase CHIP to caspases
Matthew Ravalin et al.
NATURE CHEMICAL BIOLOGY (2019)
A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington's disease patients
Peng Liu et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Asparagine endopeptidase cleaves tau at N167 after uptake into microglia
Annika Behrendt et al.
NEUROBIOLOGY OF DISEASE (2019)
A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain
Ebru Ercan-Herbst et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers
James P. Quinn et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Abolishing Tau cleavage by caspases at Aspartate421 causes memory/synaptic plasticity deficits and pre-pathological Tau alterations
F. Biundo et al.
TRANSLATIONAL PSYCHIATRY (2017)
Characterization of TauC3 antibody and demonstration of its potential to block tau propagation
Samantha B. Nicholls et al.
PLOS ONE (2017)
Tau in physiology and pathology
Yipeng Wang et al.
NATURE REVIEWS NEUROSCIENCE (2016)
Halting of Caspase Activity Protects Tau from MC1-Conformational Change and Aggregation
Emma Mead et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Caspase-2 cleavage of tau reversibly impairs memory
Xiaohui Zhao et al.
NATURE MEDICINE (2016)
Caspase-cleaved tau exhibits rapid memory impairment associated with tau oligomers in a transgenic mouse model
YoungDoo Kim et al.
NEUROBIOLOGY OF DISEASE (2016)
Arc is a flexible modular protein capable of reversible self-oligomerization
Craig Myrum et al.
BIOCHEMICAL JOURNAL (2015)
Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry
Holger Franken et al.
NATURE PROTOCOLS (2015)
New Views on the Misconstrued: Executioner Caspases and Their Diverse Non-apoptotic Roles
Nicolas Unsain et al.
NEURON (2015)
Caspase Cleavage Sites in the Human Proteome: CaspDB, a Database of Predicted Substrates
Sonu Kumar et al.
PLOS ONE (2014)
The E3 Ligase CHIP: Insights into Its Structure and Regulation
Indranil Paul et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Proteolytic Cleavage of Polymeric Tau Protein by Caspase-3: Implications for Alzheimer Disease
Jose J. Jarero-Basulto et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)
Caspase-2 is required for dendritic spine and behavioural alterations in J20 APP transgenic mice
Julio Pozueta et al.
NATURE COMMUNICATIONS (2013)
Mice lacking caspase-2 are protected from behavioral changes, but not pathology, in the YAC128 model of Huntington disease
Jeffrey B. Carroll et al.
MOLECULAR NEURODEGENERATION (2011)
The role of caspases in Alzheimer's disease; potential novel therapeutic opportunities
Troy T. Rohn
APOPTOSIS (2010)
Caspase-3 Activation via Mitochondria Is Required for Long-Term Depression and AMPA Receptor Internalization
Zheng Li et al.
CELL (2010)
A Caspase Cleaved Form of Tau Is Preferentially Degraded through the Autophagy Pathway
Philip J. Dolan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Caspase activation precedes and leads to tangles
Alix de Calignon et al.
NATURE (2010)
Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process
Bart De Strooper
PHYSIOLOGICAL REVIEWS (2010)
Accumulation of aspartic Acid421- and glutamic Acid391-Cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease
Gustavo Basurto-Islas et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species
Chad A. Dickey et al.
JOURNAL OF NEUROSCIENCE (2006)
Global hairpin folding of tau in solution
S Jeganathan et al.
BIOCHEMISTRY (2006)
Identification of VCP/p97, carboxyl terminus of Hsp70-interacting protein (CHIP), and amphiphysin II interaction partners using membrane-based human proteome arrays
G Grelle et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Morris water maze: procedures for assessing spatial and related forms of learning and memory
Charles V. Vorhees et al.
NATURE PROTOCOLS (2006)
Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease
AL Guillozet-Bongaarts et al.
NEUROBIOLOGY OF AGING (2005)
CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation
L Petrucelli et al.
HUMAN MOLECULAR GENETICS (2004)
Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease
PM Horowitz et al.
JOURNAL OF NEUROSCIENCE (2004)
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology
RA Rissman et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
The biochemical mechanism of caspase-2 activation
BC Baliga et al.
CELL DEATH AND DIFFERENTIATION (2004)
Alzheimer's missing link?
[Anonymous]
MOLECULAR THERAPY (2003)
Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
TC Gamblin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila
GR Jackson et al.
NEURON (2002)
Share Paper
